 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.5.1.46
- Deoxyhypusine synthase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
EC 2.5.1.46
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[eIF5A-precursor]-lysine + spermidine = [eIF5A-precursor]-deoxyhypusine + propane-1,3-diamine
|
 |
 |
 |
 |
 |
[eIF5A-precursor]-lysine
|
+
|
spermidine
|
=
|
[eIF5A-precursor]-deoxyhypusine
|
+
|
propane-1,3-diamine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
NAD(+)
|
 |
 |
 |
 |
 |
NAD(+)
Bound ligand (Het Group name =
NAD)
corresponds exactly
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytosol
|
1 term
|
 |
|
Biological process
|
positive regulation of cell proliferation
|
7 terms
|
 |
|
Biochemical function
|
protein binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:28697-28705
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme.NAD.inhibitor ternary complex.
|
|
T.C.Umland,
E.C.Wolff,
M.H.Park,
D.R.Davies.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Deoxyhypusine synthase catalyzes the first step in the two-step
post-translational synthesis of hypusine, which is uniquely present in
eukaryotic initiation factor 5A (eIF5A). Deoxyhypusine synthase and eIF5A are
conserved throughout the eukaryotic kingdom, and both are essential for cell
proliferation and survival. A previous study (Liao, D. I., Wolff, E. C., Park,
M. H., and Davies, D. R. (1998) Structure 6, 23-32) of human deoxyhypusine
synthase revealed four active sites of the homotetrameric enzyme located within
deep tunnels. These Form I crystals were obtained under conditions of acidic pH
and high ionic strength and likely contain an inactive enzyme. Each active-site
entrance is blocked by a ball-and-chain motif composed of a region of extended
structure capped by a two-turn alpha-helix. We report here at 2.2 A a new Form
II crystal of the deoxyhypusine synthase:NAD holoenzyme grown at low ionic
strength and pH 8.0, near the optimal pH for enzymatic activity. The
ball-and-chain motif could not be detected in the electron density, suggesting
that it swings freely and thus it no longer obstructs the active-site entrance.
The deoxyhypusine synthase competitive inhibitor N(1)-guanyl-1,7-diaminoheptane
(GC(7))is observed bound within the putative active site of the enzyme in the
new crystal form (Form II) after exposure to the inhibitor. This first structure
of a deoxyhypusine synthase.NAD.inhibitor ternary complex under physiological
conditions now provides a structural context to discuss the results of previous
biochemical investigations of the deoxyhypusine synthase reaction mechanism.
This structure also provides a basis for the development of improved inhibitors
and antiproliferative agents.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Human DHS crystal structures. A, stereoview of the
Form II DHS·NAD tetramer, with each monomer indicated by
a different color and label, and NAD in red. The black diamonds
indicate the general location of the active sites, and the blue
spheres denote Ser28. B, the DHS Form I structure (this study),
emphasizing the ball-and-chain motif obstructing an active-site
entrance. C, the Rossmann fold of the DHS monomer is green, the
mobile ball-and-chain is magenta, and the secondary structure
labeling scheme is from Ref. 15.
|
 |
Figure 4.
FIG. 4. Representations of the electrostatic surfaces
surrounding an active-site tunnel entrance of the Form II human
DHS crystal structure (A) and the homology model of HSS from a
plant (S. vulgaris) (B). Positively and negatively charged
regions are denoted as blue and red, respectively.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
28697-28705)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Woriedh,
I.Hauber,
A.L.Martinez-Rocha,
C.Voigt,
F.J.Maier,
M.Schröder,
C.Meier,
J.Hauber,
and
W.Schäfer
(2011).
Preventing fusarium head blight of wheat and cob rot of maize by inhibition of fungal deoxyhypusine synthase.
|
| |
Mol Plant Microbe Interact, 24,
619-627.
|
 |
|
|
|
|
 |
B.Chawla,
A.Jhingran,
S.Singh,
N.Tyagi,
M.H.Park,
N.Srinivasan,
S.C.Roberts,
and
R.Madhubala
(2010).
Identification and characterization of a novel deoxyhypusine synthase in Leishmania donovani.
|
| |
J Biol Chem, 285,
453-463.
|
 |
|
|
|
|
 |
B.Kerscher,
E.Nzukou,
and
A.Kaiser
(2010).
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
|
| |
Amino Acids, 38,
471-477.
|
 |
|
|
|
|
 |
M.Hoque,
H.M.Hanauske-Abel,
P.Palumbo,
D.Saxena,
D.D'Alliessi Gandolfi,
M.H.Park,
T.Pe'ery,
and
M.B.Mathews
(2009).
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
|
| |
Retrovirology, 6,
90.
|
 |
|
|
|
|
 |
R.Koike,
A.Kidera,
and
M.Ota
(2009).
Alteration of oligomeric state and domain architecture is essential for functional transformation between transferase and hydrolase with the same scaffold.
|
| |
Protein Sci, 18,
2060-2066.
|
 |
|
|
|
|
 |
S.Specht,
S.R.Sarite,
I.Hauber,
J.Hauber,
U.F.Görbig,
C.Meier,
D.Bevec,
A.Hoerauf,
and
A.Kaiser
(2008).
The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase.
|
| |
Parasitol Res, 102,
1177-1184.
|
 |
|
|
|
|
 |
E.C.Wolff,
K.R.Kang,
Y.S.Kim,
and
M.H.Park
(2007).
Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
|
| |
Amino Acids, 33,
341-350.
|
 |
|
|
|
|
 |
J.K.Huang,
Y.Cui,
C.H.Chen,
D.Clampitt,
C.T.Lin,
and
L.Wen
(2007).
Molecular cloning and functional expression of bovine deoxyhypusine hydroxylase cDNA and homologs.
|
| |
Protein Expr Purif, 54,
126-133.
|
 |
|
|
|
|
 |
J.H.Park,
L.Aravind,
E.C.Wolff,
J.Kaevel,
Y.S.Kim,
and
M.H.Park
(2006).
Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
|
| |
Proc Natl Acad Sci U S A, 103,
51-56.
|
 |
|
|
|
|
 |
J.T.Njuguna,
M.Nassar,
A.Hoerauf,
and
A.E.Kaiser
(2006).
Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax.
|
| |
BMC Microbiol, 6,
91.
|
 |
|
|
|
|
 |
M.H.Park
(2006).
The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
|
| |
J Biochem, 139,
161-169.
|
 |
|
|
|
|
 |
M.Saeftel,
R.S.Sarite,
T.Njuguna,
U.Holzgrabe,
D.Ulmer,
A.Hoerauf,
and
A.Kaiser
(2006).
Piperidones with activity against Plasmodium falciparum.
|
| |
Parasitol Res, 99,
281-286.
|
 |
|
|
|
|
 |
D.Davies,
and
D.Davies
(2005).
A quiet life with proteins.
|
| |
Annu Rev Biophys Biomol Struct, 34,
1.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|